> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# EUA for Covid Next-Generation Sequencing Test
- URL: https://www.fdaweb.com/eua-for-covid-next-generation-sequencing-test/
- Published: 2020-06-10T12:00:00.000Z
- Updated: 2026-09-14T16:17:43.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146975

FDA has issued an emergency use authorization to Illumina, Inc., for the first Covid-19 diagnostic test using next-generation sequencing technology. An agency [statement](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-next-generation-sequence-test-diagnosing-covid-19?ref=fdaweb.com) says FDA authorized the Illumina COVIDSeq test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of Covid-19 by their healthcare provider. “Using next-generation sequencing technology means that the test can generate information about the genomic sequence of the virus present in a sample, which can be also used for research purposes,” the statement says.